A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a ...

Described today in the journal Science Translational Medicine, the finding gives oncologists a new target for developing immunotherapies: double negative memory B cells, so-called because they are ...

B cells and T cells help fight off infections and are key components of our immune system. Both of these cell types can recall their interactions with harmful antigens by creating memory cells ...